Get started
Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsETFs
Full chart
Full chart

Compare with Indivior Pharmaceuticals, Inc.



Key stats


Market capitalization
‪4.34 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20.0
Basic EPS (TTM)
1.8 EUR
Net income (FY)
‪178.80 M‬ EUR
Revenue (FY)
‪1.05 B‬ EUR
Shares float
‪112.13 M‬
Beta (1Y)
−0.44

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
838
Change (1Y)
−213−20.27%
Revenue / Employee (1Y)
‪1.26 M‬ EUR
Net income / Employee (1Y)
‪213.36 K‬ EUR

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joseph J. Ciaffoni
Website
indivior.com
Headquarters
North Chesterfield
Founded
2014
ISIN
US45579U1097
CUSIP
45579U109
FIGI
BBG01ZX23RV3
Identifiers
ISIN US45579U1097
CFI code
ESVUFR
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

ETFs holding the stock


IJR
iShares Core S&P Small-Cap ETF
Weight0.28%
Market value‪300.04 M‬
VTI
Vanguard Total Stock Market ETF
Weight0.01%
Market value‪158.97 M‬
IWM
iShares Russell 2000 Index Fund
Weight0.16%
Market value‪124.26 M‬
VB
Vanguard Small-Cap ETF
Weight0.06%
Market value‪114.72 M‬
VBK
Vanguard Small-Cap Growth ETF
Weight0.14%
Market value‪66.28 M‬
XSMO
Invesco S&P SmallCap Momentum ETF
Weight2.13%
Market value‪65.20 M‬
VXF
Vanguard Extended Market ETF
Weight0.06%
Market value‪57.40 M‬
SPSM
State Street SPDR Portfolio S&P 600 Small Cap ETF
Weight0.28%
Market value‪46.70 M‬
IJT
iShares S&P SmallCap 600 Growth ETF
Weight0.56%
Market value‪46.09 M‬
IWO
iShares Russell 2000 Growth Fund
Weight0.27%
Market value‪39.50 M‬
VTWO
Vanguard Russell 2000 ETF
Weight0.15%
Market value‪28.33 M‬

Explore more ETFs 

Frequently asked questions


The current price of E7P is 35.4 EUR — it has increased by 1.15% in the past 24 hours. Watch Indivior Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Indivior Pharmaceuticals, Inc. stocks are traded under the ticker E7P.
E7P stock has risen by 0.57% compared to the previous week, the month change is a 1.73% rise, over the last year Indivior Pharmaceuticals, Inc. has showed a 31.11% increase.
We've gathered analysts' opinions on Indivior Pharmaceuticals, Inc. future price: according to them, E7P price has a max estimate of 51.59 EUR and a min estimate of 40.22 EUR. Watch E7P chart and read a more detailed Indivior Pharmaceuticals, Inc. stock forecast: see what analysts think of Indivior Pharmaceuticals, Inc. and suggest that you do with its stocks.
E7P reached its all-time high on Jul 8, 2026 with the price of 36.6 EUR, and its all-time low was 24.4 EUR and was reached on Mar 25, 2026. View more price dynamics on E7P chart.
See other stocks reaching their highest and lowest prices.
E7P stock is 1.70% volatile and has beta coefficient of −0.44. Track Indivior Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Indivior Pharmaceuticals, Inc. there?
Today Indivior Pharmaceuticals, Inc. has the market capitalization of ‪4.44 B‬, it has increased by 0.29% over the last week.
Yes, you can track Indivior Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Indivior Pharmaceuticals, Inc. is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
E7P earnings for the last quarter are 0.83 EUR per share, whereas the estimation was 0.57 EUR resulting in a 45.45% surprise. The estimated earnings for the next quarter are 0.78 EUR per share. See more details about Indivior Pharmaceuticals, Inc. earnings.
Indivior Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪274.37 M‬ EUR, despite the estimated figure of ‪236.15 M‬ EUR. In the next quarter, revenue is expected to reach ‪269.29 M‬ EUR.
E7P net income for the last quarter is ‪77.03 M‬ EUR, while the quarter before that showed ‪86.84 M‬ EUR of net income which accounts for 0.00% change. Track more Indivior Pharmaceuticals, Inc. financial stats to get the full picture.
No, E7P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 25, 2026, the company has 838 employees. See our rating of the largest employees — is Indivior Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Indivior Pharmaceuticals, Inc. EBITDA is ‪393.81 M‬ EUR, and current EBITDA margin is 30.51%. See more stats in Indivior Pharmaceuticals, Inc. financial statements.
Like other stocks, E7P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Indivior Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.